Your browser doesn't support javascript.
Bichromonol, a dimeric coumarin with anti-HIV activity from the stem bark of Hypericum roeperianum.
Fobofou, Serge A T; Franke, Katrin; Brandt, Wolfgang; Manzin, Aldo; Madeddu, Silvia; Serreli, Gabriele; Sanna, Giuseppina; Wessjohann, Ludger A.
  • Fobofou SAT; Department of Bioorganic Chemistry, Leibniz Institute of Plant Biochemistry, Halle (Saale), Germany.
  • Franke K; Institute of Pharmaceutical Biology, Technische Universität Braunschweig, Braunschweig, Germany.
  • Brandt W; Department of Bioorganic Chemistry, Leibniz Institute of Plant Biochemistry, Halle (Saale), Germany.
  • Manzin A; Department of Bioorganic Chemistry, Leibniz Institute of Plant Biochemistry, Halle (Saale), Germany.
  • Madeddu S; Department of Biomedical Sciences, University of Cagliari, Monserrato (CA), Italy.
  • Serreli G; Department of Biomedical Sciences, University of Cagliari, Monserrato (CA), Italy.
  • Sanna G; Department of Biomedical Sciences, University of Cagliari, Monserrato (CA), Italy.
  • Wessjohann LA; Department of Biomedical Sciences, University of Cagliari, Monserrato (CA), Italy.
Nat Prod Res ; : 1-7, 2022 Aug 12.
Article in English | MEDLINE | ID: covidwho-20235597
ABSTRACT
Infectious diseases caused by viruses like HIV and SARS-COV-2 (COVID-19) pose serious public health threats. In search for new antiviral small molecules from chemically underexplored Hypericum species, a previously undescribed atropisomeric C8-C8' linked dimeric coumarin named bichromonol (1) was isolated from the stem bark of Hypericum roeperianum. The structure was elucidated by MS data and NMR spectroscopy. The absolute configuration at the biaryl axis was determined by comparing the experimental ECD spectrum with those calculated for the respective atropisomers. Bichromonol was tested in cell-based assays for cytotoxicity against MT-4 (CC50 = 54 µM) cells and anti-HIV activity in infected MT-4 cells. It exhibits significant activity at EC50 = 6.6-12.0 µM against HIV-1 wild type and its clinically relevant mutant strains. Especially, against the resistant variants A17 and EFVR, bichromonol is more effective than the commercial drug nevirapine and might thus have potential to serve as a new anti-HIV lead.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Variants Language: English Journal: Nat Prod Res Year: 2022 Document Type: Article Affiliation country: 14786419.2022.2110094

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Variants Language: English Journal: Nat Prod Res Year: 2022 Document Type: Article Affiliation country: 14786419.2022.2110094